Cardiac Output Monitor

Here is a comprehensive overview of Cardiac Output Monitors, with a specific focus on minimally invasive arterial waveform analysis devices like the FloTrac/Vigileo and EV1000/VolumeView systems.

---

Introduction: What is Cardiac Output and Why Monitor It?

Cardiac Output (CO) is the volume of blood pumped by the heart per minute. It is a fundamental hemodynamic parameter that reflects the heart's ability to meet the body's metabolic demands for oxygen and nutrients.

The formula is simple: Cardiac Output (CO) = Heart Rate (HR) x Stroke Volume (SV)

• Stroke Volume (SV): The volume of blood ejected from the left ventricle with each beat.
• Cardiac Index (CI): Cardiac Output normalized to body surface area (BSA). It's a better comparison between patients of different sizes. CI = CO / BSA.

Why is it crucial to monitor CO?

• Guiding Therapy: It helps clinicians make critical decisions about fluid administration, vasopressor use (to constrict blood vessels and increase blood pressure), and inotrope use (to increase the force of heart contraction).
• Assessing Tissue Perfusion: Low CO can lead to inadequate tissue perfusion, resulting in organ dysfunction and failure (e.g., in septic shock or cardiogenic shock).
• Risk Stratification: Low CO is a known predictor of poor outcomes in critically ill patients and those undergoing high-risk surgery.

The Spectrum of Cardiac Output Monitor ing

CO monitoring exists on a spectrum from non-invasive to highly invasive:

1. Non-Invasive: (e.g., Bioreactance - NICOM, Esophageal Doppler - EDM, Transthoracic Echocardiography - TTE)

   • Pros: No arterial or central line required, lowest risk.
   • Cons: Can be less reliable, susceptible to artifact, may be intermittent (TTE).

2. Minimally Invasive: (e.g., FloTrac/Vigileo, EV1000/VolumeView, LiDCO, PiCCO)

   • Pros: Requires only a standard arterial line, provides continuous data, less risky than a PA catheter.
   • Cons: Accuracy can be affected by patient conditions and vascular tone.

3. Invasive (Gold Standard): (e.g., Pulmonary Artery Catheter - Swan-Ganz)

   • Pros: Considered the most accurate method for CO and provides additional pressures (e.g., PAOP, CVP).
   • Cons: Requires insertion of a catheter into the heart's pulmonary artery, carrying significant risks (arrhythmias, infection, pulmonary artery rupture).

This guide focuses on the Minimally Invasive category, specifically the systems that analyze the arterial pressure waveform.

---

The Technology: Arterial Pressure Waveform Analysis (APWA)

Devices like the FloTrac and EV1000 are built on the principle of arterial pressure waveform analysis. They calculate CO by analyzing the shape and characteristics of the arterial blood pressure (ABP) wave from a standard arterial line.

The Core Concept: The device's algorithm analyzes the arterial pressure waveform to determine the patient's Stroke Volume (SV). Since Heart Rate (HR) is easily measured, it can then calculate CO = HR x SV.

How does it calculate SV from a pressure wave? This is the "secret sauce" and the main difference between manufacturers. The algorithm must account for two key physiological properties:

1. Arterial Compliance: How much the aorta and major arteries stretch with each pulse of blood. Stiffer arteries (lower compliance) result in a higher pressure for a given volume of blood.
2. Systemic Vascular Resistance (SVR): The resistance to blood flow offered by the systemic vasculature.

The algorithms use complex mathematical models to estimate these properties. They continuously analyze the relationship between pressure and flow to derive SV.

---

FloTrac/Vigileo System (Edwards Lifesciences)

• FloTrac Sensor: This is the proprietary transducer that connects to the patient's arterial line. It captures the raw arterial pressure waveform.
• Vigileo Monitor: This is the bedside monitor that connects to the FloTrac sensor. It houses the algorithm that performs the calculations and displays the data.

How it Works:

1. Input: The FloTrac sensor receives the arterial pressure waveform from a standard arterial line (radial, femoral, or axillary).
2. Algorithm: The Vigileo monitor uses a proprietary algorithm that analyzes multiple aspects of the arterial waveform over a 20-second window.
3. Patient Demographics: The clinician must input patient data (age, sex, height, weight). The algorithm uses this to create a baseline estimate of the patient's arterial compliance, as compliance is known to change with age, sex, and body size.
4. Dynamic Adjustment: The algorithm continuously self-calibrates by analyzing the standard deviation of the arterial pressure. It assumes that changes in pulse pressure are proportional to changes in stroke volume, and it adjusts its calculation of vascular resistance and compliance in real-time.

Key Parameters Provided:

• Cardiac Output (CO) & Cardiac Index (CI)
• Stroke Volume (SV) & Stroke Volume Index (SVI)
• Stroke Volume Variation (SVV)
• Systemic Vascular Resistance (SVR) & Systemic Vascular Resistance Index (SVRI)

---

EV1000/VolumeView System (Edwards Lifesciences)

This is Edwards' more advanced platform, which can integrate with the FloTrac sensor but also offers a more sophisticated method.

• EV1000 Clinical Platform: A more modern, versatile monitor that can display data from various Edwards sensors.
• VolumeView Sensor: While it can use the FloTrac algorithm, its advanced feature set comes from using the VolumeView algorithm, which is a form of transpulmonary thermodilution.

How it Works (Advanced Mode):

1. Arterial Waveform Analysis: Like the Vigileo, it can perform continuous CO monitoring using the arterial pressure waveform (via a FloTrac sensor).
2. Transpulmonary Thermodilution (TPTD): For calibration and more advanced parameters, it uses a central venous catheter. A small bolus of cold saline is injected into the central vein. The sensor on the arterial line detects the change in blood temperature as it passes by.
3. Calculation: By analyzing the shape and duration of this temperature change curve, the system can very accurately calculate Cardiac Output and, crucially, derive volumetric parameters of the heart and lungs.

Key Parameters Provided (in addition to FloTrac's parameters):

• Global End-Diastolic Volume Index (GEDVI): An estimate of the patient's total preload (volume in the ventricles at the end of diastole). This is considered a more accurate indicator of preload than central venous pressure (CVP).
• Extravascular Lung Water Index (EVLWI): Measures the amount of fluid in the lungs. This is extremely useful for managing patients with conditions like ARDS or sepsis.
• Cardiac Function Index (CFI): An indicator of the contractility of the heart.

---

Clinical Applications of Cardiac Output Monitors

These monitors are invaluable in settings where precise hemodynamic management is critical:

• Operating Room (OR):
  • High-Risk Surgery: Major vascular, cardiac, transplant, and oncological surgeries where significant fluid shifts and blood loss are expected.
  • Goal-Directed Fluid Therapy (GDFT): Using dynamic parameters like Stroke Volume Variation (SVV) to guide fluid administration. A high SVV (>10-13%) suggests the patient is fluid-responsive and will benefit from a fluid bolus. This helps avoid both under-resuscitation and fluid overload.
• Intensive Care Unit (ICU):
  • Septic Shock: Guiding fluid resuscitation and titrating vasopressors (like norepinephrine) to optimize MAP and CO.
  • Cardiogenic Shock: Assessing the need for and titrating inotropes (like dobutamine) or mechanical circulatory support.
  • ARDS Management: Using EVLWI to guide fluid management and reduce pulmonary edema.

---

Advantages and Limitations

Advantages of APWA Monitors:

• Less Invasive: Only requires an arterial line, which is common in ICU/OR settings, avoiding the risks of a PA catheter.
• Continuous Data: Provides real-time, beat-to-beat updates, allowing for rapid assessment of therapeutic interventions.
• Ease of Use: Quicker to set up than a PA catheter. No need for a sterile pulmonary artery insertion procedure.
• Cost-Effective: Generally less expensive than PA catheters in terms of both device cost and staff time.

Limitations and Disadvantages:

• Accuracy Concerns: This is the most significant limitation. The accuracy of these devices is debated, especially when compared to thermodilution. Accuracy can be compromised in several clinical scenarios:
  • Arrhythmias: Especially atrial fibrillation, where beat-to-beat variability is high and irregular.
  • Low Stroke Volume States: Very low SV can lead to an unreliable signal.
  • Significant Aortic Regurgitation: The backflow of blood disrupts the pressure waveform.
  • Vasopressor/Inotrope Use: Rapid changes in vascular tone can "trick" the algorithm, as it may not adjust quickly enough.
  • Intra-Aortic Balloon Pump (IABP): The counter-pulsation of the IABP completely alters the waveform, making APWA unusable.
• "Black Box" Algorithms: The proprietary nature of the algorithms means clinicians cannot see exactly how the calculations are made.
• Dependence on a Good Arterial Waveform: Any damping, kinking of the arterial line, or patient movement can produce artifacts and inaccurate readings.
• Requires Initial Calibration Data: Incorrect patient demographic input will lead to flawed baseline calculations.

Comparison Table

---

Conclusion

Cardiac Output monitors like the FloTrac/Vigileo and EV1000/VolumeView have revolutionized hemodynamic management by providing a powerful, less-invasive alternative to the traditional pulmonary artery catheter. They offer continuous, real-time data that is invaluable for guiding fluid and vasoactive therapy, particularly in the operating room and intensive care unit.

However, they are not a perfect replacement for all situations. Clinicians must understand their underlying technology and, most importantly, their limitations. Their accuracy can be affected by common clinical conditions like arrhythmias and significant vascular tone changes. Therefore, these devices should be used as part of a comprehensive clinical assessment, which includes physical examination, laboratory values, and other monitoring modalities like ultrasound. When used judiciously and with an understanding of their strengths and weaknesses, they are an essential tool in the modern management of critically ill and high-risk surgical patients.